These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12715683)

  • 1. [From where does the economic support to health research come?].
    Schaumann B
    Ugeskr Laeger; 2003 Mar; 165(14):1468; author reply 1468. PubMed ID: 12715683
    [No Abstract]   [Full Text] [Related]  

  • 2. [From where does the economic support to health research come?].
    Højgaard L; Rehfeld JF
    Ugeskr Laeger; 2003 Jan; 165(4):346-9. PubMed ID: 12599801
    [No Abstract]   [Full Text] [Related]  

  • 3. [Corrupt research may damage public health].
    Waldum HL
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2672-3. PubMed ID: 16215620
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials in India: balancing economic opportunity with the public health context.
    Dandona L
    Natl Med J India; 2006; 19(2):57-9. PubMed ID: 16756189
    [No Abstract]   [Full Text] [Related]  

  • 5. [Does the public sector have an independent research role in the development of drugs?].
    Poulsen HE; Grønlykke TB
    Ugeskr Laeger; 2003 Apr; 165(16):1674-6. PubMed ID: 12756828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The roles and responsibilities of the pharmaceutical industry].
    Dejgaard A; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industrial health research in Canada.
    Morin Y
    CMAJ; 2007 Jun; 176(12):1734; author reply 1734. PubMed ID: 17548390
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is clinical research in Denmark directed by drug industry?].
    Jacobsen IA
    Ugeskr Laeger; 2004 Jun; 166(24):2367-8. PubMed ID: 15281581
    [No Abstract]   [Full Text] [Related]  

  • 9. [Health care in the USA depends more and more on drug industry].
    Werkö L
    Lakartidningen; 2004 Sep; 101(38):2915-7. PubMed ID: 15485176
    [No Abstract]   [Full Text] [Related]  

  • 10. Judging public health research: epistemology, public health and the law.
    Wynia MK
    Am J Bioeth; 2005; 5(6):4-7. PubMed ID: 16282101
    [No Abstract]   [Full Text] [Related]  

  • 11. [Health research--industry's point of view].
    Dejgaard A; Diderichsen B
    Ugeskr Laeger; 2003 Jan; 165(4):319-20. PubMed ID: 12599791
    [No Abstract]   [Full Text] [Related]  

  • 12. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
    Amsden GW
    Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research and the research support system].
    Rolighed A
    Ugeskr Laeger; 2003 Jan; 165(4):341-3. PubMed ID: 12599799
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medical research grant for public health, including social medicine, during the years 1968-1976].
    Pindborg JJ
    Ugeskr Laeger; 1977 Feb; 139(7):425-6. PubMed ID: 841732
    [No Abstract]   [Full Text] [Related]  

  • 15. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

  • 16. Markets and public health: pushing and pulling vaccines into production.
    Wynia MK
    Am J Bioeth; 2006; 6(3):3-6. PubMed ID: 16754439
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical research, an enterprise in creativity at the incentive of needs: a plea for an interuniversity fund of pharmacologic research].
    Christophe J
    Rev Med Brux; 1981 Apr; 2(4):347-52. PubMed ID: 7291791
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing countries take a creative approach to R&D.
    Fleck F
    Bull World Health Organ; 2005 Jan; 83(1):4-5. PubMed ID: 15682239
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug development costs are overstated by the industry].
    Jeppsson A
    Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545
    [No Abstract]   [Full Text] [Related]  

  • 20. Part 3: International evaluation of Swedish public health research.
    Kamper-Jørgensen F; Arber S; Berkman L; Mackenbach J; Rosenstock L; Teperi J
    Scand J Public Health Suppl; 2005 Jun; 65():46-84. PubMed ID: 16040452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.